M Houde

465 total citations
22 papers, 362 citations indexed

About

M Houde is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Genetics. According to data from OpenAlex, M Houde has authored 22 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 4 papers in Genetics. Recurrent topics in M Houde's work include Renin-Angiotensin System Studies (6 papers), Nitric Oxide and Endothelin Effects (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). M Houde is often cited by papers focused on Renin-Angiotensin System Studies (6 papers), Nitric Oxide and Endothelin Effects (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). M Houde collaborates with scholars based in Canada, Sweden and Japan. M Houde's co-authors include Pedro D’Orléans-Juste, Louis‐Charles Desbiens, Yves Pesant, Jackson T. Wright, K A Martin, Thomas W. Wilson, R LEWANCZUK, J Lenis, Ghassan Bkaily and Gunnar Pejler and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

M Houde

21 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Houde Canada	9	167	73	64	62	57	22	362
Minoru Kashiwagi Japan	8	93 0.6×	73 1.0×	44 0.7×	110 1.8×	61 1.1×	12	439
Jieming Mao China	11	117 0.7×	55 0.8×	61 1.0×	97 1.6×	33 0.6×	30	410
M. Pfohl Germany	7	152 0.9×	51 0.7×	66 1.0×	119 1.9×	27 0.5×	13	319
Hakan Tıkız Türkiye	11	123 0.7×	64 0.9×	22 0.3×	108 1.7×	66 1.2×	34	381
Reiko Nakashima Japan	10	60 0.4×	113 1.5×	60 0.9×	46 0.7×	30 0.5×	15	420
Alexandros X. Kortsaris Greece	10	140 0.8×	62 0.8×	38 0.6×	82 1.3×	101 1.8×	14	388
Sayuri Hiraishi Japan	11	120 0.7×	44 0.6×	24 0.4×	36 0.6×	36 0.6×	19	391
Robert Fishel United States	13	446 2.7×	78 1.1×	66 1.0×	112 1.8×	33 0.6×	20	719
Promporn Suksaranjit United States	12	374 2.2×	64 0.9×	48 0.8×	104 1.7×	50 0.9×	31	687
Nynke E. Hahn Netherlands	9	89 0.5×	79 1.1×	35 0.5×	68 1.1×	88 1.5×	14	454

Countries citing papers authored by M Houde

Since Specialization

Citations

This map shows the geographic impact of M Houde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Houde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Houde more than expected).

Fields of papers citing papers by M Houde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Houde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Houde. The network helps show where M Houde may publish in the future.

Co-authorship network of co-authors of M Houde

This figure shows the co-authorship network connecting the top 25 collaborators of M Houde. A scholar is included among the top collaborators of M Houde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Houde. M Houde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Houde, M, Adel Schwertani, Roger Lecomte, et al.. (2018). Mouse Mast Cell Protease 4 Deletion Protects Heart Function and Survival After Permanent Myocardial Infarction. Frontiers in Pharmacology. 9. 868–868. 13 indexed citations

Houde, M, et al.. (2016). Endothelin receptor antagonist macitentan or deletion of mouse mast cell protease 4 delays lesion development in atherosclerotic mice. Life Sciences. 159. 71–75. 10 indexed citations

Houde, M, Louis‐Charles Desbiens, & Pedro D’Orléans-Juste. (2016). Endothelin-1. Advances in pharmacology. 77. 143–175. 96 indexed citations

Houde, M, Julie Labonté, Hugo Gagnon, et al.. (2015). Chymase inhibitor-sensitive synthesis of endothelin-1 (1–31) by recombinant mouse mast cell protease 4 and human chymase. Biochemical Pharmacology. 94(2). 91–100. 16 indexed citations

Houde, M, Julie Labonté, Gunnar Pejler, et al.. (2013). Pivotal Role of Mouse Mast Cell Protease 4 in the Conversion and Pressor Properties of Big-Endothelin-1. Journal of Pharmacology and Experimental Therapeutics. 346(1). 31–37. 20 indexed citations

Houde, M, et al.. (2013). High salt‐induced hypertension in B₂ knockout mice is corrected by the ET_A antagonist, A127722. British Journal of Pharmacology. 170(2). 266–277. 7 indexed citations

Feldman, Debbie Ehrmann, Sasha Bernatsky, M Houde, Marie‐Eve Beauchamp, & Michał Abrahamowicz. (2012). Early consultation with a rheumatologist for RA: does it reduce subsequent use of orthopaedic surgery?. Lara D. Veeken. 52(3). 452–459. 25 indexed citations

Houde, M, Julie Labonté, & Pedro D’Orléans-Juste. (2011). Peptide and Non-peptide Antagonists Targeting Endothelin Receptors in Physiology and Pathology. Current Pharmaceutical Design. 17(25). 2613–2625. 7 indexed citations

D’Orléans-Juste, Pedro, et al.. (2008). Endothelin-1 (1–31): From chymase-dependent synthesis to cardiovascular pathologies. Vascular Pharmacology. 49(2-3). 51–62. 28 indexed citations

10.

Harvey, Isabelle, et al.. (2003). Leiomyosarcoma of Urinary Bladder Following Cyclophosphamide Therapy: Report of Two Cases. Modern Pathology. 16(5). 512–514. 31 indexed citations

11.

Houde, M, et al.. (2002). Lessons learned by building and using Scrutiny, a collaborative software inspection system. 350–357. 3 indexed citations

12.

Dandavino, R, C Beaudry, S Carrière, et al.. (1982). Cadaver kidney transplantation: a retrospective comparison of two immunosuppressive regimens.. PubMed. 14(4). 635–9. 1 indexed citations

13.

Beaudry, C, S Carrière, Jacques Friborg, et al.. (1981). [Renal transplant and rehabilitation].. PubMed. 110(2). 88–90. 1 indexed citations

14.

Dubuc, M., et al.. (1981). [Treatment of drug poisoning by tricyclic antidepressant agents: for or against the use of physostigmine].. PubMed. 110(6). 555–7. 1 indexed citations

15.

Dandavino, R, et al.. (1981). Greffe rénale et grossesse: présentation d'un cas et revue de la littérature.. 110(2). 1 indexed citations

16.

Houde, M, et al.. (1981). [Recurrence of Goodpasture's syndrome after kidney transplantation].. PubMed. 110(3). 236–9. 1 indexed citations

17.

Corvol, Pierre, et al.. (1977). [The renin-angiotensin-aldosterone system in hypertensive patients. II. Diagnosis of primary hyperaldosteronism].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 6(29). 2569–72. 2 indexed citations

18.

Beaudry, C, et al.. (1975). Early disappearance of proteinuria attributed to the original kidneys after kidney transplantation.. PubMed. 104(2). 246–8. 4 indexed citations

19.

Houde, M, et al.. (1974). [Kidney transplants. 50 cases].. PubMed. 103(6). 1051–6.

20.

Houde, M, et al.. (1973). [Meningitis due to Listeria monocytogenes. Presentation of a case and literature review].. PubMed. 103(8). 1701–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact